As pancreatic and colorectal cancer disease-free survival time is positively correlated with CXCR5+ CD8 T cell frequency (30), the maintenance of a CXCR5+ CD8 T cell population may prolong cancer treatment efficacy. This evidence concerns the gene CXCR5 and colorectal cancer.